Literature DB >> 3925741

Hemodynamic effects of nitroglycerin and long-acting nitrates.

J Abrams.   

Abstract

Nitroglycerin (NTG) and isosorbide dinitrate (ISDN) are potent dilators of vascular smooth muscle. The organic nitrates produce venodilation at very low doses, with little additional vasodilation of the venous circulation with increasing dosage. Nitrates increase arterial diameter and improve arterial conductance at low to moderate doses, and at high doses these agents produce dilation of the arteriolar or resistance vessels of the body. The overall hemodynamic response to nitrate administration will be modulated by the degree of sympathetic reflex discharge, the presence or absence of congestive heart failure, the dosage of administered nitrate, and the presence or absence of nitrate tolerance. Regional circulatory effects of the organic nitrates include a decrease in vascular resistance and an increase in arterial blood flow to the arms and legs. Venodilation also occurs in the extremities. In the splanchnic and mesenteric circulations, nitrates induce an initial vasodilative response followed by reflex vasoconstriction. Hepatic blood flow changes little in the normal state. Pulmonary blood flow decreases and pulmonary artery and venous pressures fall after nitrate administration. Renal blood flow remains essentially unchanged or decreases slightly after NTG administration, although reflex sympathetic activity may cause secondary vasoconstriction. The antianginal effects of nitrates have long been thought to be related to their systemic or peripheral actions, which reduce myocardial oxygen requirements through decreases in left ventricular preload and afterload. There is, however, considerable evidence that nitrates have important direct effects on the coronary circulation in both the normal and the ischemic heart. Such actions include coronary artery dilation, increased collateral blood flow, and enhanced oxygenation and nutrient perfusion to zones of ischemia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925741

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  31 in total

Review 1.  Advancements in pharmacotherapy for angina.

Authors:  Ankur Jain; Islam Y Elgendy; Mohammad Al-Ani; Nayan Agarwal; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2017-03-15       Impact factor: 3.889

Review 2.  An update on nitrate tolerance: can it be avoided?

Authors:  S R Maxwell; M J Kendall
Journal:  Postgrad Med J       Date:  1992-11       Impact factor: 2.401

Review 3.  Nitroglycerin use in myocardial infarction patients.

Authors:  Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Circ J       Date:  2011-11-01       Impact factor: 2.993

4.  Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure.

Authors:  J A Bauer; J P Balthasar; H L Fung
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

5.  FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.

Authors:  Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

6.  Encapsulation of a nitric oxide donor into a liposome to boost the enhanced permeation and retention (EPR) effect.

Authors:  Yu Tahara; Takuma Yoshikawa; Hikari Sato; Yukina Mori; Md Hosain Zahangir; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  Medchemcomm       Date:  2016-12-21       Impact factor: 3.597

7.  Characteristics of attenuated endothelium-dependent relaxation seen in rabbit intrapulmonary vein following chronic nitroglycerine administration.

Authors:  Nobuyoshi Kusama; Junko Kajikuri; Yoshimasa Watanabe; Yoshikatsu Suzuki; Hirotada Katsuya; Takeo Itoh
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

8.  Lack of tolerance after chronic administration of controlled-release isosorbide-5-mononitrate. Interaction of nitrate and gallopamil.

Authors:  M Stauch; G Grossmann; D Wanjura; W E Adam
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration.

Authors:  A Peix; A López; F Ponce; J Morales; A R de la Vega; C S Chesa; A M Maltas; D García-Barreto
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

10.  Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.

Authors:  Wei He; Wanda Acampa; Ciro Mainolfi; Francesco Menna; Anna Rita Sorrentino; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.